LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Denali Therapeutics and Millions of Other Companies

Sign up for full access to Denali Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Recent Collaborations Denali Therapeutics has recently partnered with Sanofi for the development of SAR443820/DNL788, indicating openness to collaborations and potential partnership opportunities for sales synergies.

Expanding Therapeutic Portfolio Through the launch and development of multiple therapeutic programs like SAR443820/DNL788 and DNL310, Denali Therapeutics is expanding its portfolio, presenting diverse product offerings that can cater to a wide range of client needs and create sales opportunities across different therapeutic areas.

Financial Stability and Funding With recent private placement equity financing of $500M and a revenue range of $50M - $100M, Denali Therapeutics demonstrates financial stability and potential for increased investment, offering a secure platform for sales partnerships and collaborations.

Targeting Major Players By engaging in significant collaborations with industry giants like Walmart, Denali Therapeutics showcases a strategic approach to targeting major players in various sectors, indicating the potential for high-value sales engagements with prominent organizations.

Innovation in Neurodegenerative Therapies Focused on developing breakthrough therapies for neurodegenerative diseases, Denali Therapeutics' innovative approach and commitment to advancing treatment options present an opportunity for sales professionals to promote cutting-edge solutions to address unmet medical needs in the market.

Similar companies to Denali Therapeutics

✕

Access Insights for Denali Therapeutics and Millions of Other Companies

Sign up for full access to Denali Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Denali Therapeutics Tech Stack

Denali Therapeutics uses 8 technology products and services including SciPy, Akamai, Squarespace, and more. Explore Denali Therapeutics's tech stack below.

  • SciPy
    Advanced Analytics And Data Science
  • Akamai
    Content Delivery Network
  • Squarespace
    Content Management System
  • NoSQL
    Database
  • Microsoft Excel
    Editors
  • ADP HRMS
    Human Resource Management System
  • JavaScript
    Programming Languages
  • HSTS
    Security

Media & News

Denali Therapeutics's Email Address Formats

Denali Therapeutics uses at least 2 format(s):
Denali Therapeutics Email FormatsExamplePercentage
FLast@dnli.comJDoe@dnli.com
71%
Last@dnli.comDoe@dnli.com
24%
First.Last@dnli.comJohn.Doe@dnli.com
5%
FLast@denalitherapeutics.comJDoe@denalitherapeutics.com
38%
First@denalitherapeutics.comJohn@denalitherapeutics.com
12%
FLast@denalitherapeutics.comJDoe@denalitherapeutics.com
38%
First@denalitherapeutics.comJohn@denalitherapeutics.com
12%

Frequently Asked Questions

Where is Denali Therapeutics's headquarters located?

Minus sign iconPlus sign iconDenali Therapeutics's main headquarters is located at 161 Oyster Point Blvd South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Denali Therapeutics's stock symbol?

Minus sign iconPlus sign iconDenali Therapeutics is a publicly traded company; the company's stock symbol is DNLI.

What is Denali Therapeutics's official website and social media links?

Minus sign iconPlus sign iconDenali Therapeutics's official website is denalitherapeutics.com and has social profiles on LinkedIn.

How much revenue does Denali Therapeutics generate?

Minus sign iconPlus sign icon As of November 2024, Denali Therapeutics's annual revenue reached $75M.

What is Denali Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconDenali Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Denali Therapeutics have currently?

Minus sign iconPlus sign iconAs of November 2024, Denali Therapeutics has approximately 450 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief People Officer: C. D.Chief Scientific Officer, Head Of Discovery: J. L.Chief Operating And Financial Officer: A. S.. Explore Denali Therapeutics's employee directory with LeadIQ.

What industry does Denali Therapeutics belong to?

Minus sign iconPlus sign iconDenali Therapeutics operates in the Biotechnology Research industry.

What technology does Denali Therapeutics use?

Minus sign iconPlus sign iconDenali Therapeutics's tech stack includes SciPyAkamaiSquarespaceNoSQLMicrosoft ExcelADP HRMSJavaScriptHSTS.

What is Denali Therapeutics's email format?

Minus sign iconPlus sign iconDenali Therapeutics's email format typically follows the pattern of . Find more Denali Therapeutics email formats with LeadIQ.

How much funding has Denali Therapeutics raised to date?

Minus sign iconPlus sign icon As of November 2024, Denali Therapeutics has raised $500M in funding. The last funding round occurred on Feb 27, 2024 for $500M.

When was Denali Therapeutics founded?

Minus sign iconPlus sign iconDenali Therapeutics was founded in 2015.
Denali Therapeutics

Denali Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families.  Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development.

Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on people’s lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.

✕

Access Insights for Denali Therapeutics and Millions of Other Companies

Sign up for full access to Denali Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
161 Oyster Point Blvd South San Francisco, California 94080 US
Website
denalitherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DNLI
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $500M

    Denali Therapeutics has raised a total of $500M of funding over 6 rounds. Their latest funding round was raised on Feb 27, 2024 in the amount of $500M.

  • $50M$100M

    Denali Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $500M

    Denali Therapeutics has raised a total of $500M of funding over 6 rounds. Their latest funding round was raised on Feb 27, 2024 in the amount of $500M.

  • $50M$100M

    Denali Therapeutics's revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Denali Therapeutics and Millions of Other Companies

Sign up for full access to Denali Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.